Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic Paravertebral Block in Hepatectomy
NCT02817321Completed
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoint: cumulative morphine consumption at 48 hours. Started Nov 2016; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02817321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817321.